# To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

> **NCT07060976** · NA · COMPLETED · sponsor: **Novamed Laboratories Pvt. Ltd.** · enrollment: 26 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **OTHER:** 18 Transdermal patches along with positive and negative controls 1)Capsaicin0.025% Topical Patch, 2)Diclofenac Diethylamine 100mg Transdermal Patch, 3)Diclofenac Diethylamine 200mg Transdermal Patch,

## Key facts

- **NCT ID:** NCT07060976
- **Lead sponsor:** Novamed Laboratories Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-21
- **Primary completion:** 2025-07-29
- **Final completion:** 2025-07-29
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060976, "To Check Dermatological Safety of Test Products by 24 Hours Patch Testing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07060976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*